Funded Startups in Misgav
Misgav’s most recent disclosed round stands out in size: Trendlines Group’s $380K (Series Unknown) on 2025-10-05 is the most recent entry, while the larges…
Misgav’s most recent disclosed round stands out in size: Trendlines Group’s $380K (Series Unknown) on 2025-10-05 is the most recent entry, while the largest disclosed round overall is Vensica Medical’s $11M on 2024-10-28, which is notably larger than the rest of the disclosed amounts (ranging from $2M to $17M). In terms of concentration, the list clusters heavily in Health Care and Biotechnology: Health Care appears in four entries (Arcuro Medical 2025-01-06 undisclosed; Vensica Medical 2024-10-28 $11M; Escala Medical 2023-06-26 $6M; Fidmi Medical 2021-10-11 $2M) and Biotechnology appears in three entries (Vensica Medical 2024-10-28 $11M; Vessi Medical 2024-02-14 $17M; Biond Biologics 2021-11-03 $15M; plus ViAqua Therapeutics 2021-06-09 $4M). Timing also shows a front-loaded run in the early 2021 to mid-2024 window, with rounds spanning 2021-06-09 through 2025-10-05 across nine rows, all associated with Misgav, Hazafon, Israel.
Most recent rounds
9 shownRelated listings
Frequently asked
What’s the largest disclosed round in Misgav in this list, and how far ahead is it of the rest of the disclosed amounts?
Vessi Medical’s $17M (Series A) on 2024-02-14 is the largest disclosed amount. It sits above the next-largest disclosed rounds such as Vensica Medical’s $11M (2024-10-28) and Biond Biologics’ $15M (2021-11-03), while other disclosed amounts cluster in single-digit to low-teens (e.g., $6M on 2023-06-26 and $4M on 2021-06-09).
Are rounds clustered in time, or are they evenly distributed across the date range shown?
They cluster rather than distribute evenly: multiple disclosed rounds land in 2024 (Vessi Medical $17M on 2024-02-14; Vensica Medical $11M on 2024-10-28) and there’s a second concentration in 2021 (ViAqua Therapeutics $4M on 2021-06-09; AgroScout $8M on 2021-08-04; Fidmi Medical $2M on 2021-10-11; Biond Biologics $15M on 2021-11-03). The range runs from 2021-06-09 through 2025-10-05 across nine rows, but most of the disclosed amounts are concentrated in 2021 and 2024.
Which sectors are most represented among the companies shown, and what does that imply for investor focus?
Health Care is the largest slice at four entries (Arcuro Medical on 2025-01-06 undisclosed; Vensica Medical 2024-10-28 $11M; Escala Medical 2023-06-26 $6M; Fidmi Medical 2021-10-11 $2M). Biotechnology appears in four entries as well (Vessi Medical 2024-02-14 $17M; Biond Biologics 2021-11-03 $15M; ViAqua Therapeutics 2021-06-09 $4M; and Vensica Medical 2024-10-28 is also labeled Health Care in the listing), indicating life-science-heavy deal flow in this Misgav set.
How much of the funding data is missing amounts or classifications like “undisclosed” or “Series Unknown”?
Out of nine rows, two entries have non-disclosed amounts: Arcuro Medical on 2025-01-06 is labeled undisclosed, and Trendlines Group on 2025-10-05 is reported as $380K but uses “Series Unknown.” In addition, several rounds are marked “Series Unknown” in the round type field (Trendlines Group 2025-10-05; Vensica Medical 2024-10-28; Escala Medical 2023-06-26), which makes stage comparisons less consistent than sector comparisons.
Which entries are most recent and oldest, and are there any notable outliers by amount within those edges?
The most recent date is 2025-10-05 for Trendlines Group at $380K (Series Unknown), which is small relative to the largest disclosed rounds in the same table (e.g., Vessi Medical $17M on 2024-02-14). The oldest date shown is 2021-06-09 for ViAqua Therapeutics at $4M, sitting below the high end created by Biond Biologics $15M (2021-11-03) and AgroScout $8M (2021-08-04).
Are there any sector-stage combinations that look unusual compared with the rest of the table?
Biotech shows a clear high-end outlier at Vessi Medical’s $17M Series A on 2024-02-14, contrasted with smaller disclosed biotech rounds like ViAqua Therapeutics $4M (2021-06-09). Meanwhile, Health Care includes both high amounts (Vensica Medical $11M on 2024-10-28; Escala Medical $6M on 2023-06-26) and low amounts (Fidmi Medical $2M on 2021-10-11), with one Health Care entry explicitly undisclosed (Arcuro Medical 2025-01-06).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.